Skip to main content

Glyphosate To Remain in Prop 65 List Supreme Court Confirms

Glyphosate To Remain in Prop 65 List Supreme Court Confirms

Glyphosate To Remain in Prop 65 List Supreme Court Confirms

Introduction

Herbicide manufacturer Monsanto's appeal to boycott the decision to tag glyphosate found in Roundup weed killer as carcinogenic was rejected by the California State's Supreme Court.

The Supreme Court's decision came as a result of the announcement by California First District Court of Appeals that the state has the authority to place glyphosate on its Proposition 65 list, which requires that products containing the herbicide must carry a cancer warning label on them. Glyphosate was added to the State's Prop 65 list last July by the California Office of Environmental Health Hazard Assessment (OEHHA) and argued Monsanto and other herbicide manufacturers to follow cancer warning label instructions for all weed killers containing glyphosate. Recently, the first Roundup trial concluded with the California jury awarding a former school district groundskeeper dying of non-Hodgkin’s lymphoma with $289 million in damages.

More than 4,000 lawsuits have been filed against Monsanto by families of individuals suffering from cancer due to contact with glyphosate found in Roundup weed killer. All lawsuits claim the manufacturer purposely neglected to warn consumers regarding the carcinogenic product. Roundup lawsuits are consolidated as a part of multidistrict litigation (MDL No. 2741; In Re: Roundup Products Liability Litigation), presided over by Judge Vince Chhabria, in the U.S. District Court of  San Francisco.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

NC to Get $150M to Boost Opioid Treatment, Recovery

Categories: Opioids

North Carolina will receive an additional $150 million from Purdue Pharma and the Sackler family as part of a national $7.4 billion settlement related to the opioid

SRI Gets FDA OK for High-Dose Naloxone Trial

Categories: Opioids

SRI has received authorization from the U.S. Food and Drug Administration (FDA) to begin Phase 1 clinical trials of a new, high-dose injectable naloxone formulation.

The approval was granted under an Investigational New Drug (IND)…

Spokane County to Get $5M in New Opioid Settlement

Categories: Opioids

Jurisdictions within Spokane County are set to receive nearly $4.7 million as part of a sweeping $7.4 billion nationwide settlement with Purdue Pharma and its owners, the Sackler family.

The agreement addresses the company’s role in fueling…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!